Abstract

BloodPAC: Establishing Standards to Accelerate Development and Approval of Liquid Biopsy Technology

Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)

The Blood Profiling Atlas in Cancer (BloodPAC) looks to improve outcomes for patients with cancer through a collaborative infrastructure that enables the sharing of information between stakeholders in industry, academia and regulatory agencies. The goals of BloodPAC are: to aggregate, make freely available, and harmonize for further analysis: i) data from CTC, ctDNA, proteins including tumor associated autoantibodies, and exosome assays, ii) associated clinical data, and iii) sample collection, preparation and handling protocols.